gaviscon cool liquid
reckitt benckiser healthcare (uk) ltd - sodium alginate; sodium bicarbonate; calcium carbonate - oral suspension - 50mg/1ml ; 26.7mg/1ml ; 16mg/1ml
gaviscon cool liquid
reckitt benckiser healthcare (uk) ltd - sodium alginate; calcium carbonate; sodium bicarbonate - oral suspension - 50mg/1ml ; 16mg/1ml ; 26.7mg/1ml
gaviscon advance mint chewable tablets
forum health products ltd - potassium bicarbonate; sodium alginate - chewable tablet - 100mg ; 500mg
gaviscon double action chewable tablets mint
reckitt benckiser healthcare (uk) ltd - sodium alginate; sodium bicarbonate; calcium carbonate - chewable tablet - 250mg ; 106.5mg ; 187.5mg
gaviscon advance oral suspension peppermint
forum health products ltd - sodium alginate; potassium bicarbonate - oral suspension - 100mg/1ml ; 20mg/1ml
gaviscon advance mint chewable tablets
reckitt benckiser healthcare (uk) ltd - potassium bicarbonate; sodium alginate - chewable tablet - 100mg ; 500mg
gabapentin capsule
unit dose services - gabapentin (unii: 6cw7f3g59x) (gabapentin - unii:6cw7f3g59x) - gabapentin is indicated for: gabapentin is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antiepileptic drugs (aeds), such as gabapentin, during pregnancy. encourage women who are taking gabapentin during pregnancy to enroll in the north american antiepileptic drug (naaed) pregnancy registry by calling the toll free number 1-888-233-2334 or visiting http://www.aedpregnancyregistry.org/ . risk summary there are no adequate data on the developmental risks associated with the use of gabapentin in pregnant women. in nonclinical studies in mice, rats, and rabbits, gabapentin was developmentally toxic (increased fetal skeletal and visceral abnormalities, and increased embryofetal mortality) when administered to pregnant animals at doses similar to or lower than those used clinically [see data] . in the u.s. general population, the estimated backg
gaviscon liquid aniseed suspension
reckitt benckinser pharmaceuticals (pty) ltd - suspension - see ingredients - each 10,0 ml contains sodium alginate 500,0 mg sodium bicarbonate 267,0 mg
gaviscon liquid peppermint suspension
reckitt benckinser pharmaceuticals (pty) ltd - suspension - see ingredients - each 10 ml suspension contains sodium alginate 500 mg
gaviscon coolmint liquid suspension
reckitt benckinser pharmaceuticals (pty) ltd - suspension - see ingredients - each 10,0 ml suspension contains sodium alginate 500,0 mg